Literature DB >> 7783750

Evidence that the hinge region plays a role in maintaining serum levels of the murine IgG1 molecule.

J K Kim1, M F Tsen, V Ghetie, E S Ward.   

Abstract

The site of the murine IgG1 molecule that regulates catabolism has recently been shown to encompass amino acids that are located at the CH2-CH3 domain interface. The CH2 and CH3 domains are connected to each other by a relatively flexible "mini-hinge" region, and flexibility in this region could clearly affect the orientation of the domains with respect to each other. The internal movement of the CH2 domain depends on the absence/presence of the hinge disulphide. The increased mobility of the CH2 domain relative to the CH3 domain in a hinge less IgG or Fc fragment may result in a conformational change at the CH2-CH3 domain interface and alter the accessibility of the residues that are involved in catabolism control. To investigate this possibility, four Fc fragments which differ in the presence/absence of hinge disulphides and hinge sequences have been analysed in both in vivo pharmacokinetic studies and in vitro by limited proteolysis with pepsin. The data show that the presence of hinge disulphide(s) in the Fc fragment results in a longer intravascular half life but a higher susceptibility to pepsin attack. This, taken together with the knowledge that pepsin cleaves close to the CH2-CH3 domain interface, suggests that the longer half life of disulphide linked Fc fragments relative to unlinked fragments may be due to conformational differences in this region of the IgG molecule, and these conformational changes may affect the accessibility of the catabolic site for binding to putative protective Fc receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783750     DOI: 10.1016/0161-5890(95)00019-b

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

Review 1.  Transcytosis and catabolism of antibody.

Authors:  Victor Ghetie; E Sally Ward
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

3.  Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line.

Authors:  B L Dickinson; K Badizadegan; Z Wu; J C Ahouse; X Zhu; N E Simister; R S Blumberg; W I Lencer
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

4.  Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity.

Authors:  Xiao-yun Liu; Laurentiu M Pop; John Schindler; Ellen S Vitetta
Journal:  MAbs       Date:  2012 Jan-Feb       Impact factor: 5.857

Review 5.  Research progress on neonatal Fc receptor and its application.

Authors:  Mangsha Hu; Shuli Wei; Wuyuan Zhou; Pingli Wang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

6.  Antibody degradation in tobacco plants: a predominantly apoplastic process.

Authors:  Verena K Hehle; Matthew J Paul; Pascal M Drake; Julian K C Ma; Craig J van Dolleweerd
Journal:  BMC Biotechnol       Date:  2011-12-30       Impact factor: 2.563

7.  Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys.

Authors:  Mario Losen; Aran F Labrijn; Vivianne H van Kranen-Mastenbroek; Maarten L Janmaat; Krista G Haanstra; Frank J Beurskens; Tom Vink; Margreet Jonker; Bert A 't Hart; Marina Mané-Damas; Peter C Molenaar; Pilar Martinez-Martinez; Eline van der Esch; Janine Schuurman; Marc H de Baets; Paul W H I Parren
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.